Log has written
SUNDAY, NOVEMBER 29, 2009 12:51 PM IST
Intas Pharmaceuticals Ltd
  
Bhuma Shrivastava  01:39 AM | September 29,2007
The drug maker, which is ranked 16th in the Rs34,000 crore Indian domestic market, will dilute about 10% in the initial public offer (IPO)